ANTIDIARRHEAL THERAPY - PROSPECTS FOR NEW AGENTS

[1] ALIMENTS J, 1977, CELL TISSUE RES, V185, P465

[2] PHARMACOLOGY OF ANTIDIARRHEAL DRUGS [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 : 279 - 301

[3] AZADKHAN AK, 1977, LANCET, V2, P892

[4] BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X

[5] BINDER HJ, 1980, REGULATORY PEPTIDE S, V1, P510

[6] BROWN DR, 1984, J PHARMACOL EXP THER, V231, P114

[7] BUKHAVE K, 1980, GASTROENTEROLOGY, V78, P32

[8] Bukhave K, 1980, Adv Prostaglandin Thromboxane Res, V8, P1627

[9] CAMPIERI M, 1978, LANCET, V2, P993

[10] CARTER RF, 1978, GASTROENTEROLOGY, V74, P726

[1] ALIMENTS J, 1977, CELL TISSUE RES, V185, P465

[2] PHARMACOLOGY OF ANTIDIARRHEAL DRUGS [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 : 279 - 301

[3] AZADKHAN AK, 1977, LANCET, V2, P892

[4] BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X

[5] BINDER HJ, 1980, REGULATORY PEPTIDE S, V1, P510

[6] BROWN DR, 1984, J PHARMACOL EXP THER, V231, P114

[7] BUKHAVE K, 1980, GASTROENTEROLOGY, V78, P32

[8] Bukhave K, 1980, Adv Prostaglandin Thromboxane Res, V8, P1627

[9] CAMPIERI M, 1978, LANCET, V2, P993

[10] CARTER RF, 1978, GASTROENTEROLOGY, V74, P726